[1]
A. M. Zahran, “Could the Immune Modulation of Invariant Natural Killer T Cell and the Expression of CD244 and CD196 on Natural Killer Cell Subtypes Impact the Treatment Outcomes of Acute Myeloid Leukemia Patients?”, J Hematol, vol. 15, no. 4, pp. 198–213, Jan. 2026, doi: 10.14740/jh2209.